Bound by Science, Bent by Politics: Inside the FDA’s Reversals and Walkbacks as It Grapples With the Coronavirus Pandemic
- Featured Faculty
- Michael Gerrard Andrew Sabin Professor of Professional Practice
The media looks to Columbia Law experts to provide ideas, opinions, analysis, and commentary on news of the day. Explore more below.
By Clara Long and Elora Mukherjee
Over the course of this summer, the American people -- across party lines -- have shown that they reject the hate and dehumanization of immigrants that appears to have motivated last weekend's mass shooting in El Paso. . . . But the test is whether legislators will use the power of the purse to make a real difference for children by keeping families together and shifting the focus away from detention. With senators and representatives home for the August recess, the American people have a pivotal opportunity to demand change now.
By John C. Coffee Jr.
The SEC and Elon Musk need to reach a settlement fast. Although Musk continues to trip over his oversized ego and sense of his own infallibility, the SEC is facing its own serious problem: Can it still enforce the consent decrees that it relies upon to make companies and executives comply with its settlements?